ChromoTek Nano-Traps with Nanobodies
01 August, 2021Available from ChromoTek are three Nano-Traps with the Nanobody coupled to the Magnetic Particles M-270. These are the GFP-Trap, RFP-Trap and Spot-Trap.
GeneTex recombinant antibodies
03 June, 2021GeneTex offers over 300 recombinant antibodies for research into SARS-CoV-2, apoptosis, immune checkpoints, cytoskeleton, JNK signalling and more.
ProSci cytokine storm research antibodies and proteins
04 May, 2021The cytokine storm is still a relatively recent discovery, scientifically speaking, and is actively being studied. ProSci enhances this type of research through supplying high-performance antibodies and recombinant proteins for investigating IFNs, ILs, TNF, chemokines, CSF and growth factors.
The Native Antigen Company recombinant SARS-CoV-2 spike mutants
01 May, 2021To support the investigation of SARS-CoV-2 variants, The Native Antigen Company offers a growing range of recombinant mutant spike antigens.
Tick-transmitted brain disease may be treatable
15 April, 2021Researchers have found antibodies capable of neutralising tick-borne encephalitis (TBE), a viral infectious disease transmitted by tick bites.
Aves Labs anti-green fluorescent protein antibody
14 April, 2021Aves Labs' anti-green fluorescent protein antibody (GFP) is a highly cited chicken polyclonal antibody, having gained over 1300 citations worldwide.
Abcam recombinant antibodies
17 March, 2021Abcam's recombinant antibodies overcome the limitations of traditional antibody production to provide a high level of consistency between batches, reproducibility, confirmed specificity and a long-term supply.
AdipoGen Life Sciences APO-1-3 and APO-1-1 apoptosis-inducing antibodies
16 February, 2021AdipoGen Life Sciences' anti-Fas clones APO-1-3 and APO-1-1 are monoclonal antibodies that recognise human Fas and are capable of inducing Fas-mediated apoptosis.
Cancer drug delivered on a MOF
15 February, 2021Loading a cancer immunotherapy drug onto a metal–organic framework improves both its delivery and its sustained release for treating leukaemia.
Researchers fast-track antibody development
10 February, 2021Researchers have developed a method that fast-tracks the passage of biopharmaceuticals from the lab to clinical trials — from as long as two years to just six months.
Exalpha Biologicals Recombinant Mouse anti-human CD56/NCAM antibody
14 December, 2020The antibody has been validated for use in flow cytometry, immunocytochemistry and immunohistochemistry with both frozen and paraffin-embedded tissue samples.
Proteintech CoraLite fluorescent-dye conjugated antibodies
01 December, 2020Proteintech's monoclonal and polyclonal antibodies are now available directly conjugated with fluorescent dyes: CoraLite488, CoraLite594 and CoraLite647. They act as useful tools for immunofluorescence studies requiring multiplex co-labelling studies without the need for secondary antibodies.
ViroStat Marburg virus monoclonal antibodies
16 November, 2020ViroStat has released several monoclonal antibodies to the Marburg virus — one of the causes of viral haemorrhagic fever.
GeneTex SARS-CoV/SARS-CoV-2 (COVID-19) spike antibody [1A9]
30 October, 2020GeneTex's SARS-CoV/SARS-CoV-2 (COVID-19) spike antibody [1A9] detects both SARS-CoV spike and SARS-CoV-2 spike proteins.
AdipoGen Life Sciences tubulin products for neurodegeneration research
22 October, 2020AdipoGen Life Sciences offers a broad range of microtubule research solutions. This includes tubulin-specific antibodies, unique and validated post-translational modification-specific antibodies and Rab1-GTP and Rab6-GTP specific antibodies.
